Current approaches to therapy of ALK-positive non-small cell lung cancer

This article analyzes approaches of the treatment of ALK-positive non-small cell lung cancer (NSCLC). Despite the relatively small percentage of patients with ALK-gene rearrangements, identification of this mutation is very important. The most effective treatment for patients with ALK translocation...

Full description

Bibliographic Details

Published in:	Медицинский совет
Main Authors:	К. К. Laktionov, S Yu. Kruteleva, Е. V. Reutova
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2021-06-01
Subjects:	non-small cell lung cancer alk translocation alk inhibitors resistance crizotinib lorlatinib ceretinib alectinib brigatinib
Online Access:	https://www.med-sovet.pro/jour/article/view/6207